APGE
Apogee Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.70 / 10
Netural
Capital flow assessment yields 7.54/10, reflecting robust liquidity with positive net inflows. However, analyst sentiment is mixed: three institutions report Neutral to Strong Buy ratings, but historical win rates vary widely (0% to 66.7%), underscoring uncertainty in forward-looking guidance.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-07
InstitutionWolfe Research
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for APGE?
- APGE holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.70/10 (Netural).
